News | June 11, 2009

FDA Calls Class I Recall on Some Medtronic Kappa, Sigma Pacemakers

June 11, 2009 - Medtronic Inc. yesterday said the FDA has classified Medtronic’s previously announced physician advisory about a small subset of Kappa and Sigma series pacemakers, identified at increased susceptibility for separation of bonded interconnect wires from the electronic circuit, as a class I recall.

Notification to FDA, physicians and patients began May 18. As of the date of this news release, more than 95 percent of physicians following affected devices in the U.S. have confirmed receipt of the notification. The FDA’s classification of Medtronic’s Important patient safety Information does not alter the patient management recommendations already provided in the May 2009 letter, and physicians need not take any new action.

Not all Medtronic Kappa and Sigma pacemakers are included in the advisory. Medtronic’s May 2009 communication to physicians involves a small subset of approximately 2 percent of the 1.7 million Kappa and Sigma pacemakers implanted worldwide since 1997. Medtronic has identified an increased susceptibility for separated interconnect wires in a specific subgroup of 10,000 of these devices in the U.S. that remain in patients. Most of the devices in the potentially affected subset have been implanted for five years or longer and may be nearing normal elective replacement time, Medtronic said.

In this limited subset of Kappa and Sigma series pacemakers, the issue can lead to loss of rate response, premature battery depletion, loss of telemetry, or no output, potentially causing patient symptoms such as fainting and lightheadedness, Medtronic said. Patients who experience these symptoms are reminded to seek medical attention immediately.

Patients can determine if their device is included in the identified subset by entering their device serial number at www.KappaSigmaSNList.medtronic.com. Patients whose serial numbers match any of those found on the Web site should contact their physician to determine an appropriate course of action. Patients without Internet access, or who have these models of devices but are unsure if their devices are included in this advisory may also contact Medtronic Patient Services at (800) 551-5544.

After consultation with the company’s Independent Physician Quality Panel, Medtronic’s May 2009 letter recommended that physicians consider device replacement for patients who are both pacemaker dependent and who have been implanted with a device in the affected subsets. Physicians should continue routine follow up in accordance with standard practice for those patients who are not pacemaker dependent.

For more information: www.medtronic.com

Related Content

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization

Mexican government reports conclude more than half of the population does not have access to social security or private insurance that covers a pacemaker implant, and 44 percent live in poverty. Recycling donated, explanted pacemakers offers a new option for these patients.

News | Pacemakers| November 10, 2017
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers| March 22, 2017
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing pro
Micra leadless pacemaker, CMS, medicare reimbursement
News | Pacemakers| March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Medtronic, Micra TPS pacemaker, Global Clinical Trial, Cardiostim 2016
News | Pacemakers| June 09, 2016
Medtronic plc announced new results from the Medtronic Micra Transcatheter Pacing System (TPS) Global Clinical Trial in...
Medtronic, Micra TPS, transcatheter pacing system, pacemaker, Jersey Shore University Medical Center, New Jersey first
News | Pacemakers| June 06, 2016
Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to...
Overlay Init